Form 4: Cintas Director Martin Mucci Receives Equity Grant
Insider Transaction Report
Cintas Corporation Director Martin Mucci was granted 503 restricted shares of common stock and options to purchase 1,694 shares of common stock as part of the company's equity plan.
Summary
- Martin Mucci, a Director of Cintas Corp (CTAS), acquired 503 shares of Common Stock and options to purchase 1,694 shares of Common Stock.
- The transaction date for both acquisitions was October 29, 2025.
- The options have an exercise price of $183.9 per share.
- Both the restricted shares and stock options were granted pursuant to Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan.
- The restricted shares and stock options are subject to a cliff vesting schedule, vesting on the first anniversary of the grant date.
- Following these transactions, Martin Mucci directly beneficially owns 3,124 shares of Common Stock.
- Following these transactions, Martin Mucci directly beneficially owns 1,694 derivative securities (stock options).
Sentiment
Score: 7
Explanation: The acquisition of restricted stock and stock options by a director indicates a positive alignment of interests with shareholders and potential confidence in the company's future performance.
Positives
- Director Martin Mucci received an equity grant, which aligns his interests with those of the company's shareholders.
- The grants are part of an established equity and incentive compensation plan, indicating a structured approach to executive and director compensation.
Future Outlook
The equity grants, including restricted shares and stock options, are structured to cliff vest on the first anniversary of the grant date, aligning the director's long-term interests with the company's performance and future value creation.
Related Party Transactions
- Grant of 503 restricted shares of common stock and options for 1,694 shares to Director Martin Mucci as part of Cintas Corporation's 2016 Amended and Restated Equity and Incentive Compensation Plan.
Stakeholder Impact
- Shareholders: Increased alignment of Director Martin Mucci's financial interests with long-term shareholder value through equity ownership.
Next Steps
- Vesting of 503 restricted shares on October 29, 2026.
- Vesting of options for 1,694 shares on October 29, 2026.
- Potential exercise of stock options by their expiration date of October 29, 2035.
Key Dates
| Date | Description |
|---|---|
| 10/29/2025 | Transaction date for the acquisition of common stock and stock options. |
| 10/29/2026 | Estimated vesting date for the 503 restricted shares and options for 1,694 shares (first anniversary of grant date). |
| 10/29/2035 | Expiration date for the stock options. |
| 10/31/2025 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThe filing reports a routine equity grant to a director, which is a positive signal for aligning management and shareholder interests. However, this event alone is typically not sufficient to alter an investment recommendation without broader fundamental analysis.
Keywords
Cintas, CTAS, Form 4, Insider Transaction, Equity Grant, Stock Options, Restricted Stock, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.